Manuel Posada de la Paz – författare
Visar alla böcker från författaren Manuel Posada de la Paz. Handla med fri frakt och snabb leverans.
3 produkter
3 produkter
Del 1031 - Advances in Experimental Medicine and Biology
Rare Diseases Epidemiology: Update and Overview
Inbunden, Engelska, 2017
2 463 kr
Skickas inom 10-15 vardagar
The fields of rare diseases research and orphan products development continue to expand with more products in research and development status. In recent years, the role of the patient advocacy groups has evolved into a research partner with the academic research community and the bio-pharmaceutical industry. Unique approaches to research and development require epidemiological data not previously available to assist in protocol study design and patient recruitment for clinical trials required by regulatory agencies prior to approval for access by patents and practicing physicians.
E-bok
Engelska, 20173 137 kr
Läs direkt efter köp
The fields of rare diseases research and orphan products development continue to expand with more products in research and development status. In recent years, the role of the patient advocacy groups has evolved into a research partner with the academic research community and the bio-pharmaceutical industry. Unique approaches to research and development require epidemiological data not previously available to assist in protocol study design and patient recruitment for clinical trials required by regulatory agencies prior to approval for access by patents and practicing physicians.
Del 1031 - Advances in Experimental Medicine and Biology
Rare Diseases Epidemiology: Update and Overview
Häftad, Engelska, 2018
2 463 kr
Skickas inom 10-15 vardagar
The fields of rare diseases research and orphan products development continue to expand with more products in research and development status. In recent years, the role of the patient advocacy groups has evolved into a research partner with the academic research community and the bio-pharmaceutical industry. Unique approaches to research and development require epidemiological data not previously available to assist in protocol study design and patient recruitment for clinical trials required by regulatory agencies prior to approval for access by patents and practicing physicians.